Loading...

Full-fledged legal support for a pharmaceutical company

Pepeliaev Group’s lawyers have advised one of the 10 world’s largest pharmaceutical companies on a broad spectrum of issues concerning its current activities: interaction with distributors, amending the commercial policy, important aspects of the circulation of orphan medicines as well as legal nuances of the circulation of medicines in the markets of some former USSR countries. 

Back to the list

15.12.2025
Pepeliaev Group has strengthened its position in the “PRO Bankruptcy Leaders” ranking of law firms
Read more
11.12.2025
Sergey Pepeliaev joins the working group of the Agency for Strategic Initiatives
Read more
05.12.2025
Pepeliaev Group has expanded its presence in the Pravo-300 ranking in 2025
Read more